← Open Payments lookup

BOLAJI OLUGBOJA: Open Payments

NPI 1689005043 · RANDALLSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$955 in 44 payments from 10 companies in 2025. Trend: 2023 $956 · 2024 $815 · 2025 $955

Food & beverage: $940Education: $15
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$264
Alkermes, Inc.12$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$106
Vanda Pharmaceuticals Inc.4$88
E.R. Squibb & Sons, L.L.C.3$69
Otsuka America Pharmaceutical, Inc.3$64
Indivior Inc.2$59
Janssen Pharmaceuticals, Inc2$52
Lundbeck LLC2$50
ABBVIE INC.1$25

Products named: INGREZZA, ARISTADA, CAPLYTA, FANAPT, COBENFY, REXULTI, SUBLOCADE, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.